Monday, March 20, 2017
SetPoint Medical Adds New Enterprise Associates As Investor
Valencia-based biomed startup SetPoint Medical announced this morning that it has received a new investment from New Enterprise Associates. Size of the investment, and details of the round, were not announced by the company. SetPoint said that NEA joins Morgenthaler Ventures, Boston Scientific, Topspin Partners, Medtronic, and GlaxoSmithKline's Action Potential Venture Capital Limited as an investor in the company. As part of the investment, Setpoint is adding Josh Makower, General Partners at NEA, to its board. SetPoint is developing treatments for inflammatory, autoimmune diseases.